Form 4: KORU Medical Systems Director Acquires Shares

Matin Shahriar, a Director at KORU Medical Systems, Inc., reported the acquisition of 3,571 shares of common stock on July 1, 2026.

Summary

• Matin Shahriar, a Director at KORU Medical Systems, Inc. (KRMD), has reported a transaction involving the acquisition of company stock.
• The transaction, dated July 1, 2026, involved the acquisition of 3,571 shares of common stock.
• The acquisition was made at a price of $4.20 per share.
• Following this transaction, Shahriar beneficially owns 101,144 shares of KORU Medical Systems' common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine insider transaction without providing new financial or strategic information.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition of 3,571 shares by a director indicates a direct investment in the company's equity.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider transactions, such as director stock purchases, are closely watched by the market as potential indicators of management's view on the company's valuation and future performance within the medical systems industry.

Stakeholder Impact

• Shareholders may view the director's purchase as a positive signal of confidence in the company's future.
• Employees may be encouraged by the investment from a key member of the board.

Key Dates

Keywords

KORU Medical Systems, KRMD, Form 4, Insider Trading, Director Transaction, Stock Acquisition, Beneficial Ownership